Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
721.30
-24.80 (-3.32%)
At close: Nov 14, 2024
-15.21%
Market Cap 1.73B
Revenue (ttm) 205.24M
Net Income (ttm) 10.68M
Shares Out 2.40M
EPS (ttm) 4.45
PE Ratio 162.07
Forward PE n/a
Dividend 1.50 (0.21%)
Ex-Dividend Date Dec 3, 2024
Volume 7,076
Open 769.00
Previous Close 746.10
Day's Range 718.00 - 778.00
52-Week Range 650.00 - 1,002.70
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 10, 2024

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal and anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 477
Stock Exchange Dhaka Stock Exchange
Ticker Symbol AMBEEPHA
Full Company Profile

Financial Performance

In 2023, Ambee Pharmaceuticals's revenue was 198.10 million, an increase of 9.45% compared to the previous year's 180.99 million. Earnings were 9.09 million, an increase of 12.79%.

Financial Statements

News

There is no news available yet.